Cargando…
Update on the use of sildenafil in neonatal pulmonary hypertension: a narrative review of the history, current administration, and future directions
Pulmonary hypertension (PH) is a life-threatening syndrome in neonates and has multiple and varied etiologies. However, few clinical studies have systematically evaluated the treatment regimens for this population. Phosphodiesterase (PDE) inhibitors, such as milrinone, tadalafil, dipyridamole, and s...
Autores principales: | Li, Zhenyu, Lv, Xiaoming, Liu, Qinmei, Dang, Dan, Wu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107873/ https://www.ncbi.nlm.nih.gov/pubmed/34012848 http://dx.doi.org/10.21037/tp-20-277 |
Ejemplares similares
-
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010) -
Fetal myelomeningocele repair: a narrative review of the history, current controversies and future directions
por: Yamashiro, Kaeli J., et al.
Publicado: (2021) -
Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial
por: Chetan, Chinmay, et al.
Publicado: (2022) -
Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006) -
Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals
por: de Souza, Ana HA, et al.
Publicado: (2009)